Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • onconaut
    Junior Member
    • Aug 2012
    • 7

    #1

    Manual Quality Control for Variant Calls

    Hello all SEQers,

    I am trying to find some documentation or leads on strategies for the manual quality control of variants that have been called in a whole exome sequencing experiment.

    The closest I got was in the GATK 'best practices' summary which basically tells you to check if the variants 'look good'. Obviously this leaves a lot of room for interpretation, but this is the closest thing I have found to a documentation of a strategy. All sequencing papers I have found will describe the pipeline and filters to some degree, but then do not touch the topic of manual review and why they would exclude some of the variants.

    Can someone in this community point me towards a publication or share their 'secret sauce' in terms of manual review strategies?

    Thanks, O.
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #2
    'Looks good' is in the eye of the beholder, but common metrics include sequencing depth (more is better), variant present on reads from both strands (strand-specific variants are more likely to be false-positives), mapping quality, and complexity of the alignment (i.e., nearby indels increase the likelihood of false-positive SNP calls).

    Blue Collar Bioinformatics blog (here) has benchmarked several variant-calling workflows (including GATK best practices) against the NIST standard Genome-in-a-Bottle. Data and workflows can be downloaded/replicated, so you can see for yourself what constitutes 'good' and 'bad'-looking variant calls.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...